We found a higher gene expression of MCP-1, IL-13, IL-31, and TNF-α in CST-14 treated MC (implying a pathogenic role of MRGPRX2-in AD pathogenesis), which were significantly reduced by GE1111. The gene discussed is CCL2; the disease is Alzheimer disease.